InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.08
(
0.19%
)
Bitcoin
57,094.41
(
-5.10%
)
Post# of 252482
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 120
Posts 20748
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Member Level

Re: DewDiligence post# 251311

Friday, 03/29/2024 3:28:39 PM

Friday, March 29, 2024 3:28:39 PM

Post# of 252482
TLPH. as follow up
https://pubmed.ncbi.nlm.nih.gov/38292627/

Conclusion: Treatment of patients showing end-stage renal failure with Nafamostat mesylate can significantly improve therapeutic efficacy and has high safety and clinical value.



https://www.tandfonline.com/doi/full/10.1080/0886022X.2022.2105233?src=recsys

Kiwi
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up